Concepedia

Joseph Dudash

JD

3

Publications

165

Citations

3

H-Index

2003

Active since

Affiliations

Johnson & Johnson (United States)(Current)

Joseph Dudash is an author at Johnson & Johnson (United States) specializing in drug discovery, medicine, and medicinal chemistry.

Top concepts

MedicinePharmacologyDrug DiscoveryMedicinal ChemistryDiabetesBiochemistryNatural SciencesGlycobiologyMetabolomicsPharmacotherapy

Publications per year

2003–2005

3

Publications

3

Synthesis and evaluation of 3-anilino-quinoxalinones as glycogen phosphorylase inhibitors

Joseph Dudash, Yong‐Zheng Zhang, John B. Moore et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 77 citations · Full text

Medicinal Chemistry, Medicine, Glycogen Phosphorylase Inhibitors +4

Benzoxazinones as PPARγ Agonists. 2. SAR of the Amide Substituent and In Vivo Results in a Type 2 Diabetes Model

Philip J. Rybczynski, Roxanne E. Zeck, Joseph Dudash et al. · Journal of Medicinal Chemistry · 2003 · 47 citations · Full text

Ap2 Gene, Pharmacotherapy, Ppargamma Agonist Activity +17

Glycosylated dihydrochalcones as potent and selective sodium glucose co-transporter 2 (SGLT2) inhibitors

Joseph Dudash, Xiaoyan Zhang, Roxanne E. Zeck et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 41 citations · Full text

Medicinal Chemistry, Glycosylation, Biochemistry +10

Rows per page

1–3 of 3